Post

Everest inches towards clinical studies for renal disease drug in China

Everest Medicines is on track to commence clinical trials in China for its renal disease drug candidate, following the acceptance …

Daré Bioscience launches Phase III hormone-free contraceptive trial

US biopharma firm Daré Bioscience has started a Phase III trial investigating the effectiveness and safety of Ovaprene, a hormone-free …

Signal: Absci and AstraZeneca sign deal on AI-powered cancer antibody drug

Pharmaceuticals giant AstraZeneca has closed on a deal with US-based biotech Absci Corporation to develop an antibody therapy for an …

Palvella and Ligand partner for Phase III rare lymphatic tumour trial

Palvella Therapeutics has partnered with Ligand Pharmaceuticals for the Phase III clinical trial investigating topical Qtorin rapamycin for the treatment …

Qnovia’s inhaled smoking cessation therapy triumphs in first clinical study

Pharmaceutical company, Qnovia has shared positive results from initial clinical trials of its prescription inhaled smoking cessation therapy. The drug delivery …